Conversely, the percent of Ki-67 positive cells was lowest in tumors with sh-HOTAIR plus oxaliplatin therapy (Fig. 7E), indicating the tumor cell proliferation was largely arrested by the treatment of sh-HOTAIR and oxaliplatin. This evidence concerns the gene MKI67 and neoplasm.